3-(4-Hydroxy-3,5-dimethoxyphenyl)propanoic acid, 97+%, 1g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[tris(1-methylethyl)silyl]oxazole, 98%, 100mg

Methyl 3-chloro-2-fluoro-5-(trifluoromethyl)benzoate, 97%, 250mg

4,4,5,5-Tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane, 97%, 5g

Analytical and precision balance Quintix® series Standard models, factory calibrated, 0.1 g, 5100 g, 5101-1CEU

3-Methylpiperidine, 95.0%, 500ml

6-Chloro-1-methyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid, 97.0%, 250mg

5-(4-Chlorophenyl)cyclohexane-1,3-dione, 97.0%, 5g

1/? first red plate 530 nm in slide for incident illumination of iScope models for polarization

5-BROMO-4-CHLORO-7-(PHENYLSULFONYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 250mg

Methyl 5H-pyrrolo[2,3-b]pyrazine-2-carboxylate, 95.0%, 5g

Boc-L-Isoleucine, 98.0%, 100g

Potassium (R,E)-2-((4-ethoxy-4-oxobut-2-en-2-yl)amino)-2-phenylacetate, 95.0%, 5g